QNCX
QNCX
NASDAQ · Biotechnology

Quince Therapeutics Inc

$0.14
-0.01 (-4.79%)
As of Feb 8, 2:30 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 548.9K 523.5K 509.5K
Net Income 128.1K 108.5K 123.6K
EPS
Profit Margin 23.3% 20.7% 24.3%
Rev Growth +23.9% +19.4% -4.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.85M 2.90M 3.28M
Total Equity 4.40M 4.55M 4.34M
D/E Ratio 0.65 0.64 0.76
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 177.1K 173.7K 174.5K
Free Cash Flow 145.7K 139.2K 108.0K